Show results for
Refine by
Vaccines Vaccination Equipment Supplied In Sweden
27 equipment items found
Manufactured by:Scandinavian Biopharma based inSolna, SWEDEN
BCG Vaccine AJVaccines contains bacteria of the type Mycobacterium bovis BCG and is used for protection against tuberculosis ...
Manufactured by:Scandinavian Biopharma based inSolna, SWEDEN
BCG Vaccine AJVaccines contains bacteria of the type Mycobacterium bovis BCG and is used for protection against tuberculosis ...
Manufactured by:Scandinavian Biopharma based inSolna, SWEDEN
diTekiBooster is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of four years ...
Manufactured by:Scandinavian Biopharma based inSolna, SWEDEN
diTekiBooster is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of four years ...
Manufactured by:Scandinavian Biopharma based inSolna, SWEDEN
diTeBooster is a vaccine that provides protection against diphtheria and tetanus. This booster vaccine is used to vaccinate children (5 years or older) and adults who have already received primary vaccination against diphtheria and ...
Manufactured by:Scandinavian Biopharma based inSolna, SWEDEN
Tuberculin PPD RT 23 AJVaccine is used as a skin test to diagnose if you have ever been infected with a bacteria causing ...
Manufactured by:Scandinavian Biopharma based inSolna, SWEDEN
Tuberculin PPD RT 23 AJVaccine is used as a skin test to diagnose if you have ever been infected with a bacteria causing ...
Manufactured by:Scandinavian Biopharma based inSolna, SWEDEN
Vivotif is indicated for active oral immunisation against typhoid fever, caused by Salmonella enterica serovar Typhi, (S. Typhi), in adults and children aged five years and ...
Manufactured by:2A Pharma ApS based inAalborg Øst, DENMARK
Head and neck cancers represent the sixth most common cancer worldwide, resulting in more than 350,000 deaths/year. Our AAVLP-HNC vaccine uses our mimotope selection technology and has the potential to minimize side effects, improve efficacy, and markedly reduce treatment costs. This will address an unmet medical need and benefit cancer patients as well as reduce healthcare ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Novavax' saponin-based Matrix-M improves immune responses and enables vaccine dose-sparing. Matrix-M adjuvant is a valuable component of vaccine development, providing multiple immune system enhancements, a well-understood mechanism of action, and robust clinical experience where it was shown to be well tolerated in human studies to ...
Manufactured by:2A Pharma ApS based inAalborg Øst, DENMARK
2A Pharma’s B-cell epitope vaccine candidate, AAVLP-IgE, has in laboratory tests with non-human primates been shown to be effective at inducing anti-IgE autoantibodies. This gives the potential for a vaccine with similar benefits to approved anti-human immunoglobulin E (IgE) antibody treatments of, for example, asthma, nut allergy etc. Currently, the ...
Premium
Manufactured by:Bertin Technologies based inMontigny-le-Bretonneux, FRANCE
Compact and safe, Sterilwave 100 transforms bio-hazardous waste into unrecognizable and inert municipal waste thanks to a 100% electric process combing shredding and microwave sterilization in one single vessel with a 100L capacity. Particularly adapted to small medical facilities such as vaccination centers, Sterilwave 100 treats biomedical waste with a bacterial inactivation up ...
Manufactured by:2A Pharma ApS based inAalborg Øst, DENMARK
2A Pharma’s anti-autoimmune vaccine candidate has potential in a number of indications. The vaccine is currently being tested in a vitiligo model in collaboration with different ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Historically, we developed a vaccine candidate against MERS, a novel coronavirus first identified in 2012, as well as a vaccine candidate against SARS in 2005. In 2012, within weeks of obtaining the sequence of the circulating MERS strain, we successfully produced a vaccine candidate. Our MERS candidate was based on the major surface spike ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Historically, we developed a vaccine candidate against MERS, a novel coronavirus first identified in 2012, as well as a vaccine candidate against SARS in 2005. In 2012, within weeks of obtaining the sequence of the circulating MERS strain, we successfully produced a vaccine candidate. Our MERS candidate was based on the major surface spike ...
Manufactured by:2A Pharma ApS based inAalborg Øst, DENMARK
2A Pharma’s anti-amyloid-beta vaccine candidate, AAVLP-Amyloid-β, has in laboratory tests with transgenic mice over-expressing amyloid-beta mutant protein been shown to eliminate amyloid-beta soluble protein, a clear plaque from the cortex and significantly reduce plaque from the hippocampus. ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Our recombinant nanoparticle vaccine technology combines the power and speed of genetic engineering to efficiently produce a new class of highly immunogenic particles that target a variety of viral pathogens. Our recombinant vaccine engineering takes a new approach to provide robust and functional immunity, which may be more efficacious than naturally occurring ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
We have developed an EBOV glycoprotein vaccine candidate (Ebola GP vaccine) expressed in insect cells, using our core recombinant baculovirus technology. In 5 separate studies, carried out in collaboration with the National Institute of Allergy and Infectious Diseases, active immunization with the Ebola GP vaccine was shown to be highly ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
With the ongoing development of our NanoFlu™ and RSV F vaccines, a strong rationale exists for developing a combination respiratory vaccine that is designed to protect susceptible populations against both diseases. Although testing is at an early stage, we believe that a combination vaccine against both seasonal influenza and RSV may be ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Older adults (aged 60 years and older) are at increased risk for RSV disease due in part to immunosenescence, the age-related decline in the human immune system. RSV infection can also lead to exacerbation of underlying comorbidities such as chronic obstructive pulmonary disease, asthma, and congestive heart failure. In the United States alone, a reported RSV incidence rate of 5.5% in older ...